Comestible products, for example beverage products, are disclosed containing encapsulated probiotic bacteria having resistance to subjection to at least thermal and acidic conditions. Beverage products include at least one aqueous liquid and capsules comprising a gelled mixture of alginate and denatured protein, and probiotic bacteria entrapped within the gelled mixture. The average particle size of the capsules is optionally less than 1000 microns (μm) in diameter, such as less than 500 μm in diameter. Methods are provided for making such encapsulated probiotics by providing a mixture comprising sodium alginate, denatured protein and active probiotic cells, and combining the mixture with a divalent cation to initiate cold gelation of the sodium alginate and denatured protein to form a second mixture. The second mixture is passed through an opening having a diameter of less than 1000 μm to form capsules. The weight ratio of protein to alginate is from 1:1 to 9:1.

The present invention relates to a topical composition comprising plant extracts. In particular, the present invention relates to a topical composition comprising plant extracts embedded in hydrophilic vesicles (niosomes), preferably having a size smaller than 500 nm, and at least one topically acceptable excipient.

The present invention is related to the method for producing the cathode material, cathode material and lithium-ion battery. The present invention provides the higher capacity and number of recharge cycles. The lithium battery comprises the metallic lithium anode, electrolyte and a cathode comprising metallic current collector coated with a suspension (concentration 0.1-1 g/mL) of composite material comprising V.sub.2O.sub.5 nanorods in graphene shell, dissolved in acetone.

A method of encapsulating content with calcium alginate membrane to form a capsule. The method includes embedding sodium alginate into a traditional gelatin ribbon used in gelatin encapsulation, adding calcium to a fill material, encapsulating the fill material, and then denaturing the gelatin in the shell. An exemplary use of this method is to form throwable paintballs; however, other products could be formed using this process. A paintball formed by this process is also disclosed.

The invention relates to a process for coating water-insoluble solids by ionic gelation employing negatively-charged macromolecules and a source of polyvalent cations as film-forming materials, wherein the coating material represents not more than 10% (w/w) with regard to the total weight of the coated solid. The coated insoluble solids may be subsequently dried to generate surface-modified dry particles for use as active ingredients and/or excipients in the manufacture of pharmaceutical compositions or food products.

The present invention relates to an extinguishing composition and comprises an extinguishing material and a capsule containing the extinguishing material, and the extinguishing material comprises calcium bromide (CaBr2).

A high amylose starch-based capsule, which includes an oily core and a breakable shell composition surrounding the oily core. The breakable shell composition is a gelled matrix derived from a gellable mixture including a partially-gelatinized high amylose starch, a hydrocolloid gelling agent, and optionally a filler. The high amylose starch based capsule is breakable under the application of a sufficient amount of force. The high amylose starch-based capsules have sufficient rigidity to maintain their integrity while incorporating into bulk matrices, such as chewing gums or compressed tablet.

A composite includes a polymer; and a phase-change composition including an unencapsulated first phase-change material, and an encapsulated second phase-change material.

A cosmetic composition comprising a plurality of capsules and a cosmetic base is provided.

Biomedical devices for implantation with decreased pericapsular fibrotic overgrowth are disclosed. The device includes biocompatible materials and has specific characteristics that allow the device to elicit less of a fibrotic reaction after implantation than the same device lacking one or more of these characteristic that are present on the device. Biocompatible hydrogel capsules encapsulating mammalian cells having a diameter of greater than 1 mm, and optionally a cell free core, are disclosed which have reduced fibrotic overgrowth after implantation in a subject. Methods of treating a disease in a subject are also disclosed that involve administering a therapeutically effective amount of the disclosed encapsulated cells to the subject.